Roundtable: Exploring Methods to Prevent Immunogenicity & Tumorgenicity of iPSC Therapies

Time: 1:30 pm
day: Day 2 Track 1 PM Clarice


  • Reviewing methods to control iPSC therapies post administration to increase therapy safety
  • Looking at utilizing gene-editing to incorporate a controllable suicide safety switch
  • Exploring the possibility of switches to control individual cells instead of cell populations to prevent whole cell suicide